Shannon Rhodes

7.8k total citations · 2 hit papers
63 papers, 5.5k citations indexed

About

Shannon Rhodes is a scholar working on Neurology, Epidemiology and Surgery. According to data from OpenAlex, Shannon Rhodes has authored 63 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 10 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Shannon Rhodes's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Hepatitis C virus research (5 papers). Shannon Rhodes is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Hepatitis C virus research (5 papers). Shannon Rhodes collaborates with scholars based in United States, France and Canada. Shannon Rhodes's co-authors include Sally C. Morton, Margaret Maglione, Paul G Shekelle, Walter Mojica, Marika J Suttorp, Lara Hilton, Beate Ritz, Lisa R. Shugarman, Jeff M. Bronstein and Ninh T. Nguyen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Annals of Internal Medicine.

In The Last Decade

Shannon Rhodes

63 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-Analysis: Surgical Treatment of Obesity

2005 1.1k citations Melinda A. Maggard, Lisa R. Shugarman et al. Annals of Internal Medicine profile →
Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults

2005 597 citations Joshua Chodosh, Sally C. Morton et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shannon Rhodes United States	31	1.2k	1.1k	903	695	658	63	5.5k
Ignasi Gich Spain	44	1.9k 1.5×	799 0.7×	1.0k 1.1×	369 0.5×	294 0.4×	240	7.1k
Maryse Lapeyre‐Mestre France	46	868 0.7×	1.6k 1.5×	514 0.6×	682 1.0×	948 1.4×	435	9.0k
Mona Boaz Israel	45	1.6k 1.3×	761 0.7×	1.1k 1.2×	191 0.3×	381 0.6×	274	7.8k
Mario Barbagallo Italy	53	627 0.5×	1.2k 1.1×	2.6k 2.9×	353 0.5×	339 0.5×	295	8.8k
Jean‐Louis Montastruc France	51	1.1k 0.9×	898 0.8×	854 0.9×	369 0.5×	2.7k 4.1×	458	10.5k
Yechiam Ostchega United States	36	928 0.7×	1.4k 1.3×	624 0.7×	591 0.9×	171 0.3×	69	6.2k
Antonella Zambon Italy	39	808 0.6×	470 0.4×	801 0.9×	363 0.5×	342 0.5×	194	6.5k
Bernard L. Silverman United States	37	837 0.7×	1.7k 1.5×	460 0.5×	249 0.4×	328 0.5×	102	6.6k
Tsai‐Chung Li Taiwan	45	713 0.6×	675 0.6×	1.3k 1.4×	282 0.4×	274 0.4×	325	7.2k
Yoshiyuki Ohno Japan	44	1.3k 1.0×	741 0.7×	556 0.6×	237 0.3×	396 0.6×	202	6.3k

Countries citing papers authored by Shannon Rhodes

Since Specialization

Citations

This map shows the geographic impact of Shannon Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Rhodes more than expected).

Fields of papers citing papers by Shannon Rhodes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Rhodes. The network helps show where Shannon Rhodes may publish in the future.

Co-authorship network of co-authors of Shannon Rhodes

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Rhodes. A scholar is included among the top collaborators of Shannon Rhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Rhodes. Shannon Rhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rhodes, Shannon, Yu Aoki, Takuya Hashimoto, et al.. (2024). 1420P Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein overexpression and biomarker overlap in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC). Annals of Oncology. 35. S885–S886. 3 indexed citations

Kelsey, Michelle D., Courtney Page, Brooke Alhanti, et al.. (2021). Lipoprotein(a) Testing Patterns in a Large Health System. The American Journal of Cardiology. 153. 43–50. 18 indexed citations

Mosnier, Émilie, Mathieu Nacher, Paul Brousse, et al.. (2019). Knowledge, attitudes, practices about HIV and implications in risk and stigma prevention among French Guianese and Brazilian border inhabitants. BMC Public Health. 19(1). 1633–1633. 7 indexed citations

Rhodes, Shannon, et al.. (2015). Inter-operator and inter-device agreement and reliability of the SEM Scanner. Journal of Tissue Viability. 24(1). 17–23. 32 indexed citations

Paul, Kimberly C., Janet S. Sinsheimer, Shannon Rhodes, et al.. (2015). Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene–Pesticide Interactions in a Case–Control Study of Parkinson’s Disease, California (USA). Environmental Health Perspectives. 124(5). 570–577. 49 indexed citations

Rhodes, Shannon, Arthur G. Fitzmaurice, Myles Cockburn, et al.. (2013). Pesticides that inhibit the ubiquitin–proteasome system: Effect measure modification by genetic variation in SKP1 in Parkinson׳s disease. Environmental Research. 126. 1–8. 38 indexed citations

Lee, Pei‐Chen, Shannon Rhodes, Janet S. Sinsheimer, Jeff M. Bronstein, & Beate Ritz. (2013). Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure. Environment International. 56. 42–47. 46 indexed citations

Fitzmaurice, Arthur G., Shannon Rhodes, Aaron Lulla, et al.. (2012). Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proceedings of the National Academy of Sciences. 110(2). 636–641. 152 indexed citations

Gatto, Nicole M., Shannon Rhodes, Angelika D. Manthripragada, et al.. (2010). α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease. Neuroepidemiology. 35(3). 191–195. 45 indexed citations

10.

Kwon, Soonil, et al.. (2009). Application of Bayesian classification with singular value decomposition method in genome-wide association studies. BMC Proceedings. 3(S7). S9–S9. 6 indexed citations

11.

Su, Xiaowen, Leland J. Yee, Shannon Rhodes, et al.. (2008). Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C. Journal of Hepatology. 49(2). 184–191. 41 indexed citations

12.

Yee, Leland J., David E. Kleiner, Dai Wang, et al.. (2007). Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology. 46(1). 74–83. 10 indexed citations

13.

Mularski, Richard A., Sydney M. Dy, Lisa R. Shugarman, et al.. (2007). A Systematic Review of Measures of End‐of‐Life Care and Its Outcomes. Health Services Research. 42(5). 1848–1870. 155 indexed citations

14.

Chodosh, Joshua, Sally C. Morton, Walter Mojica, et al.. (2005). Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults. Annals of Internal Medicine. 143(6). 427–438. 597 indexed citations breakdown →

15.

Maggard, Melinda A., Lisa R. Shugarman, Marika J Suttorp, et al.. (2005). Meta-Analysis: Surgical Treatment of Obesity. Annals of Internal Medicine. 142(7). 547–559. 1100 indexed citations breakdown →

16.

Farmer, Douglas G., Sue V. McDiarmid, Hasan Yersiz, et al.. (2004). Improved outcome after intestinal transplantation at a single institution over 12 years. Transplantation Proceedings. 36(2). 303–304. 11 indexed citations

17.

Shekelle, Paul G, Erin Stone, Margaret Maglione, et al.. (2003). Interventions to Promote Smoking Cessation in the Medicare Population. 1 indexed citations

18.

Shekelle, Paul, Sally C. Morton, Mary Hardy, et al.. (2003). Ephedra: Is It Worth the Risk?. RAND Corporation eBooks. 1 indexed citations

19.

Shekelle, Paul G, Michael W. Rich, Sally C. Morton, et al.. (2003). Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status. Journal of the American College of Cardiology. 41(9). 1529–1538. 337 indexed citations

20.

Rhodes, Shannon. (2001). Real time detection and compensation of registration errors in a network of radars. 2001. 4–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact